C. Renoux

First name
C.
Last name
Renoux
Dimakos, J., Cui, Y., Platt, R. W., Renoux, C., Filion, K. B., & Douros, A. (2022). Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes Care. http://doi.org/10.2337/dc22-1584
View
Rahman, A., Michaud, J., Dell'Aniello, S., Moodie, E. E. M., Brophy, J. M., Durand, M., et al. (2022). Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study. Neurology. http://doi.org/10.1212/wnl.0000000000206748
View
Cao, T. X. D., Filliter, C., Montastruc, F., H. Y. Yu, O., Fergusson, E., Rej, S., et al. (2022). Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. J Affect Disord, 318, 231-237. http://doi.org/10.1016/j.jad.2022.08.094
View
Durand, M., Schnitzer, M. E., Pang, M., Carney, G., Eltonsy, S., Filion, K. B., et al. (2021). Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi-database cohort study with meta-analysis. Br J Clin Pharmacol, 87, 2589-2601. http://doi.org/10.1111/bcp.14669
View
Moodie, E. E. M., Coulombe, J., Danieli, C., Renoux, C., & Shortreed, S. M. (2022). Privacy-preserving estimation of an optimal individualized treatment rule: a case study in maximizing time to severe depression-related outcomes. Lifetime Data Anal. http://doi.org/10.1007/s10985-022-09554-8
View
Khosrow-Khavar, F., Azoulay, L., Montastruc, J. L., Montastruc, F., & Renoux, C. (2022). Aromatase inhibitors and the incidence of Parkinson disease: A population-based cohort study. Cancer. http://doi.org/10.1002/cncr.34208
View
Chowdhury, R., Michaud, J., H. Y. Yu, O., Yin, H., Azoulay, L., & Renoux, C. (2022). Effectiveness and safety of apixaban vs. rivaroxaban in patients with atrial fibrillation and type 2 diabetes mellitus. Thromb Haemost. http://doi.org/10.1055/a-1798-2116
View
Pradhan, R., Patorno, E., Tesfaye, H., Schneeweiss, S., Yin, H., Franklin, J., et al. (2022). Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study. Am J Epidemiol. http://doi.org/10.1093/aje/kwac021
View
Renoux, C., Dell'Aniello, S., Garbe, E., & Suissa, S. (2008). Hormone replacement therapy use and the risk of stroke. Maturitas. http://doi.org/10.1016/j.maturitas.2008.09.020
View
Renoux, C., Dell'Aniello, S., & Suissa, S. (2010). Hormone replacement therapy and the risk of venous thromboembolism: a population-based study. J Thromb Haemost. http://doi.org/10.1111/j.1538-7836.2010.03839.x
View